This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
15, 2020 /PRNewswire/ — Seattle Gummy Company’s breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company’s allergy gummy medication, designated as IND 140312.
CNIC scientists have discovered previously unsuspected actions of the immune system that help to maintain organ health Credit: CNIC Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have discovered that neutrophils, the most abundant cells of the innate immune system, have many more functions in the body than previously thought. (..)
But scientists at Uppsala University and the University Hospital have now identified a mechanism they believe to be implicated. Why so many COVID-19 patients get blood clots (thrombosis) remains uncertain. A particular protein triggers a part of our immune system that can boost the blood’s tendency to coagulate and form clots.
From the beginning, most scientists have said that COVID-19 is deadlier than the seasonal flu, while fringe theories have circulated […]. Data analysis offers comparison of the 2 viruses Almost a year ago, COVID-19 began its global rampage, going on to infect about 69.5 million people and kill about 1.6 million as of early this month.
Bayer’s primary focus lies in prescription products, including cardiology and women’s healthcare, along with therapeutics in oncology, hematology and ophthalmology. It also has a significant presence in consumer health sectors such as dermatology, nutritionals and allergy. The company is headquartered in Mainz, Germany.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content